白术内酯I在制备用于抑制乳腺癌肺转移药物中的应用

本发明公开了白术内酯I在制备用于抑制乳腺癌肺转移药物中的应用。本发明提供了白术内酯I的一种新用途，其可降低乳腺癌细胞的肺部转移能力。当白术内酯I作为药物使用时，乳腺癌荷瘤小鼠实验表明，白术内酯I能够显著抑制乳腺癌肺转移的发生发展，并且对小鼠体重无显著影响，具有较高的安全性。因此，白术内酯I有望开发成新的抑制乳腺癌肺转移的药物。 The invention discloses application of atractylenolide I in preparation of a medicine for inhibiting lung metastasis of breast cancer....

Full description

Saved in:
Bibliographic Details
Format Patent
LanguageChinese
Published 22.04.2025
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:本发明公开了白术内酯I在制备用于抑制乳腺癌肺转移药物中的应用。本发明提供了白术内酯I的一种新用途，其可降低乳腺癌细胞的肺部转移能力。当白术内酯I作为药物使用时，乳腺癌荷瘤小鼠实验表明，白术内酯I能够显著抑制乳腺癌肺转移的发生发展，并且对小鼠体重无显著影响，具有较高的安全性。因此，白术内酯I有望开发成新的抑制乳腺癌肺转移的药物。 The invention discloses application of atractylenolide I in preparation of a medicine for inhibiting lung metastasis of breast cancer. The invention provides a new application of atractylenolide I. The atractylenolide I can reduce the lung metastasis capability of breast cancer cells. When the atractylenolide I is used as a medicine, a breast cancer tumor-bearing mouse experiment shows that the atractylenolide I can obviously inhibit the occurrence and development of breast cancer lung metastasis, has no obvious influence on the weight of a mouse, and has relatively high safety. Therefore, atractylenolide I is expected to be developed into a novel medicine for inhibiting lung metastasis of breast cancer.
Bibliography:Application Number: CN202411435614